References:

[1] Chernock R, Hagemann I. Molecular Pathology of Hereditary and Sporadic Medullary Thyroid Carcinomas. Am J Clin Pathol. 2015;143(6):768-777.
[2] Cibas E, Ducatman B. Cytology Diagnostic Principles And Clinical Correlates. 4th ed. Philadelphia, PA: Saunders/Elsevier; 2014:289-290.
[3] Layfield L. Cytopathology Of The Head And Neck. Hong Kong: American Society of Clinical Pathologists; 1997:175-176, 193-194.
[4] Thompson L, Wenig B, Muller S, Nelson B. Diagnostic Pathology Head And Neck. 2nd ed. Philadelphia, PA: Elsevier; 2016:1030-1041.
[5] Wells S, Asa S, Dralle H et al. Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma. Thyroid. 2015;25(6):567-610.
[6] Pacheco M. Multiple Endocrine Neoplasia: A Genetically Diverse Group of Familial Tumor Syndromes. J Pediatr Genet. 2016;05(02):89-97.
[7] Gnepp D. Diagnostic Surgical Pathology Of The Head And Neck. 2nd ed. Philadelphia, PA: Saunders/Elsevier; 2009:606-613.
[8] DeLellis R, Lloyd R, Heitz P, Eng C. WHO Classification Tumours Of Endocrine Organs. Lyon: International Agency for Research on Cancer; 2008:51-52, 86-93, 210-212.
[9] Ali S, Cibas E. The Bethesda System For Reporting Thyroid Cytopathology. 1st ed. New York, NY: Springer; 2010:117-128.
[10] ImmunoQuery | Get It Right. Right Now. Immunoquery.com. https://www.immunoquery.com/. Published 2019. Accessed July 15, 2019.
[11] Nikiforov Y. Thyroid carcinoma: molecular pathways and therapeutic targets. Modern Pathology. 2008;21(S2):S37-S43.
[12] Kniffin C. OMIM Entry - # 155240 - THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC. Omim.org. https://www.omim.org/entry/155240. Published 2019. Accessed July 17, 2019.
[13] Pstrąg N, Ziemnicka K, Bluyssen H, Wesoły J. Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates. Mol Cancer. 2018;17(116):1-17.